Ah yes Scotty90, I have heard of this and like the stem cell treatments this may one day be used in combo with iPPS. I believe it is a PRP type solution.
Certainly a totally different strategy and I believe it wont have quite the widespread, mass appeal, efficacy as we are showing so far.
Durolane is also a product that must be injected into the joint itself thus won't have the 'healing' properties for more than one (all) joints at the same time and address inflammation all over as again we have displayed..
There was some AE's displayed in a few studies. It's not a solution for everyone though appears to have some good results as well.
DYOR is best policy
Reference:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967379/
research reports and media, page-1186
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 181098 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 118621 | 5 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |